Catalyst Wire Dossier Catalyst Wire Dossier

Denosumab CP2

denosumab · Amgen
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Denosumab CP2, covering 2017-12-29 to 2017-12-29. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Denosumab CP4 Drug Product and Commercially Available Denosumab CP2 Drug Product [Phase 1]

See pricing